HF
GSK icon

HRT Financial’s GSK GSK Stock Holding History

HRT Financial’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.5M Buy
425,687
+129,940
+44% +$7.04M 0.06% 297
2025
Q4 		$14.5M Buy
+295,747
New +$13.8M 0.05% 315
2025
Q3 		– Sell
-31,370
Closed -$1.2M – 3171
2025
Q2 		$1.2M Buy
+31,370
New +$1.2M 0.01% 1177
2024
Q4 		– Sell
-110,739
Closed -$4.53M – 2708
2024
Q3 		$4.53M Buy
+110,739
New +$4.53M 0.02% 502
2024
Q2 		– Sell
-180,021
Closed -$7.72M – 2542
2024
Q1 		$7.72M Sell
180,021
-336,563
-65% -$13.9M 0.05% 179
2023
Q4 		$19.1M Buy
516,584
+498,066
+2,690% +$17.9M 0.14% 79
2023
Q3 		$671K Buy
+18,518
New +$657K 0.01% 1234
2022
Q4 		– Sell
-85,793
Closed -$2.52M – 2724
2022
Q3 		$2.52M Buy
85,793
+73,983
+626% +$2.8M 0.03% 523
2022
Q2 		$642K Buy
11,810
+16
+0.1% +$883 0.01% 1308
2022
Q1 		$642K Buy
+11,794
New +$641K ﹤0.01% 1447
2021
Q2 		– Sell
-58,177
Closed -$2.6M – 3106
2021
Q1 		$2.6M Buy
+58,177
New +$2.64M 0.03% 487
2019
Q2 		– Sell
-4,332
Closed -$226K – 811
2019
Q1 		$226K Buy
+4,332
New +$216K 0.04% 359
2018
Q4 		– Sell
-4,661
Closed -$234K – 659
2018
Q3 		$234K Buy
+4,661
New +$237K 0.04% 301
2017
Q2 		– Sell
-3,806
Closed -$200K – 100
2017
Q1 		$200K Buy
+3,806
New +$193K 0.19% 95

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

HRT Financial's GSK Position: Q1 2026 in Review

HRT Financial increased its GSK (GSK) stake by 44% in Q1 2026, buying an estimated $7.04M and bringing the position to 425,687 shares worth $23.5M. The position accounts for 0.06% of the portfolio, ranked #297.

HRT Financial first reported a position in GSK in Q1 2017 and has held it in 14 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • HRT Financial held 425,687 shares of GSK worth $23.5M as of Q1 2026.
  • HRT Financial bought 129,940 GSK shares in Q1 2026, an estimated $7.04M.
  • GSK made up 0.06% of HRT Financial's portfolio in Q1 2026, its #297 holding.
  • HRT Financial first reported a position in GSK in Q1 2017 and has held it in 14 quarters since.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.